Next Article in Journal
Insights into Circulating Tumor Cell Clusters: A Barometer for Treatment Effects and Prognosis for Prostate Cancer Patients
Previous Article in Journal
Effects of Green Tea Catechins on Prostate Cancer Chemoprevention: The Role of the Gut Microbiome
Previous Article in Special Issue
Resistance to TKIs in EGFR-Mutated Non-Small Cell Lung Cancer: From Mechanisms to New Therapeutic Strategies
 
 
Review
Peer-Review Record

Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLC

Cancers 2022, 14(16), 3983; https://doi.org/10.3390/cancers14163983
by Jennifer Novak 1, Ravi Salgia 2, Howard West 2, Miguel A Villalona-Calero 2, Sagus Sampath 1, Terence Williams 1, Victoria Villaflor 2, Erminia Massarelli 2, Ranjan Pathak 2, Marianna Koczywas 2, Brittney Chau 1 and Arya Amini 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Cancers 2022, 14(16), 3983; https://doi.org/10.3390/cancers14163983
Submission received: 14 July 2022 / Revised: 2 August 2022 / Accepted: 16 August 2022 / Published: 18 August 2022
(This article belongs to the Special Issue Mechanisms of Resistance in EGFR-Mutated Non-Small Cell Lung Cancer)

Round 1

Reviewer 1 Report

The manuscript is easier to read after the changes made. 

Congrats to the authors for the manuscript and persistence required to complete this review. 

Minor changes:

In methods, "randomized" appears repeated. 

Author Response

the repeated word "randomized" has been removed from the methods section

Reviewer 2 Report

The comments raised by the previous reviewer were responded well.

Author Response

Thank you

Back to TopTop